1Lassaletta A, Scheinemann K, Zelcer SM, et al. Phase II weekly vinblastine for chemotherapy-naïve children with progressive low-grade glioma: a Canadian Pediatric Brain Tumor Consortium Study. J Clin Oncol. 2016; 34: 3537-3543.
10.1200/JCO.2016.68.1585
CAS PubMed Web of Science® Google Scholar
2Lafay-Cousin L, Sung L, Carret A-S, et al. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience. Cancer. 2008; 112: 892-899.
10.1002/cncr.23249
CAS PubMed Web of Science® Google Scholar
3Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008; 122: 574-580.
10.1016/j.jaci.2008.02.044
CAS PubMed Web of Science® Google Scholar
4Genc DB, Canpolat C, Berrak SG. Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. Support Care Cancer. 2012; 20: 385-393.
10.1007/s00520-011-1123-y
PubMed Web of Science® Google Scholar
5Dodgshun AJ, Hansford JR, Cole T, Choo S, Sullivan MJ. Carboplatin hypersensitivity reactions in pediatric low grade glioma are protocol specific and desensitization shows poor efficacy. Pediatr Blood Cancer. 2016; 63: 17-20.
10.1002/pbc.25686
CAS PubMed Web of Science® Google Scholar
6Sloane D, Govindarajulu U, Harrow-Mortelliti J, et al. Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies. J Allergy Clin Immunol Pract. 2016; 4: 497-504.
10.1016/j.jaip.2015.12.019
PubMed Web of Science® Google Scholar
7Gururangan S, Cavazos CM, Ashley D, et al. Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol. 2002; 20: 2951-2958.
10.1200/JCO.2002.12.008
CAS PubMed Web of Science® Google Scholar
8Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004; 114: 371-376.
10.1016/j.jaci.2004.04.029
PubMed Web of Science® Google Scholar
9Shah AC, Minturn JE, Li Y, et al. Carboplatin rechallenge after hypersensitivity reactions in pediatric patients with low-grade glioma. Pediatr Blood Cancer. 2016; 63: 21-26.
10.1002/pbc.25697
CAS PubMed Web of Science® Google Scholar
10Sancho-Serra Mdel C, Simarro M, Castells M. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization. Eur J Immunol. 2011; 41: 1004-1013.
10.1002/eji.201040810
CAS PubMed Web of Science® Google Scholar
11Vidal C, Méndez-Brea P, López-Freire S, et al. A modified protocol for rapid desensitization to chemotherapy agents. J Allergy Clin Immunol Pract. 2016; 4: 1003-1005.
10.1016/j.jaip.2016.05.015
PubMed Web of Science® Google Scholar
12Lax T, Long A, Banerji A. Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions. J Allergy Clin Immunol Pract. 2015; 3: 856-862.
10.1016/j.jaip.2015.07.003
PubMed Web of Science® Google Scholar
13Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D, et al. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Allergy. 2013; 68: 853-861.
10.1111/all.12105
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume29, Issue1

February 2018

Pages 111-115

Initial experience with carboplatin desensitization: A case series in a paediatric hospital

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Initial experience with carboplatin desensitization: A case series in a paediatric hospital

REFERENCES

Citing Literature

References

Related

Information